Welcome to the Other Cancers Studies Page
Do you have a diagnosis of metastatic castration-resistant prostate cancer? If so, you may be interested in this study that will help researchers determine whether adding a study drug, called talazoparib, to an existing prostate cancer drug, called enzalutamide, provides any additional benefit to patients when compared to taking enzalutamide with a placebo (no medication).
Do you have kidney cancer (renal cell carcinoma) that is advanced or has spread to other parts of your body, and have not yet been treated? If so, you may be interested in a study to see whether a combination of two investigational new drugs is safe and effective in slowing down the growth of your kidney cancer.
Did you have surgery for high-risk prostate cancer and currently have a rising PSA (prostate-specific antigen) level? If so, you may be eligible to participate in a research study to help compare three different hormonal treatments to find out which one is the most effective for lowering PSA levels and slowing or stopping the return of prostate cancer.
Interested in sharing your story about health, illness, or research? Patients and caregivers are needed to participate in a research study to help learn more about topics that are important to you and that may improve health and health care. Participation involves one 45-minute session that takes place over the phone. Eligible participants must be able to read and understand English.
Have you been diagnosed with relapsed (comes back) or refractory (did not get better) multiple myeloma? If so, you may be eligible to participate in a study to help researchers test whether an investigational (experimental) drug called venetoclax combined with dexamethasone works better than the combination of pomalidomide and dexamethasone to treat multiple myeloma. Compensation provided.
Do you have a rare genitourinary (GU) tumor? If so, you may be eligible to participate in a study to help researchers test the good and bad effects of three combined cancer drugs, called cabozantinib, nivolumab, and ipilimumab, that are FDA-approved individually, but not in combination.
Have you been diagnosed with prostate cancer that has spread? Have you already undergone treatment with hormone therapy and docetaxel (chemo drug)? If so, you may be eligible to participate in a study to help researchers test any good or bad effects of using the chemotherapy drug cabazitaxel (Jevtana) combined with standard of care treatment compared to people on standard of care treatment alone.
Have you been diagnosed with squamous cell carcinoma (SCC) on your lower extremity (below the knee)? If so, you may be eligible to participate in a study to help researchers determine if the need for surgical treatment of SCC can be eliminated by injecting a solution of a chemotherapeutic drug.
Are you a man with a past or current cancer diagnosis? If so, you may be able to participate in a research study to help better understand how men with cancer stand up for themselves (called “self-advocacy”). Involves completing questionnaires (paper or online) that will take about 30-45 minutes. Compensation provided.
Are you a man who has been diagnosed with prostate or head and neck cancer within the past 3 months? If so, you may be able to participate in a research study to help learn more about how men with cancer stand up for themselves (called “self-advocacy”). Involves 3 interviews over 6 months. Compensation provided.
Have you been successfully treated for a tobacco-related head and neck cancer in the past five years? If so, you may be able to participate in a research study to help learn more about the effects of a dietary supplement called Avmacol®. Avmacol is made up of broccoli seed, broccoli sprout extract, and vitamin C, and may help reduce inflammation and boost the immune system. Compensation provided.
Did you have bladder cancer that was completely surgically removed? Are you 18-84 years old? If so, you may be able to take part in a research study investigating how lifestyle changes affect weight, fitness level, quality of life, and certain biomarkers in people with a history of non-metastatic bladder cancer (BC). Compensation provided.
You may be able to change the future of medicine. The All of Us PA Research Program is enrolling adults 18 years of age or older. This may be your chance to improve how your children and your children’s children receive medical care.
Will you receive treatment for a medical condition that may result in your infertility, and want to preserve your ovarian tissue to possibly allow you to have your own children in the future? You may be able to take part in a research study to develop techniques for long-term preservation of ovarian function through freezing of ovarian tissues.
Are you a man who will receive treatment for a medical condition that may result in infertility (inability to have your own children)? You may be able to participate in a research study to develop ways to preserve testicular tissue and possibly preserve fertility.
Are you a man age 18-50 who is scheduled to undergo treatment with chemotherapy for a medical condition? If so, you may be able to participate in a research study to find out if the sperm collected shortly after starting chemotherapy is safe and effective for future use.
